Chutes & Ladders—Third Rock’s cardiometabolic biotech unveils C-suite

 Chutes and LaddersWelcome to this week’s Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here at the end of each week. 

Marea unveils C-suite and cardiometabolic program

Marea Therapeutics

Third Rock Ventures’ Marea has unveiled with $190 million and a mid-stage clinical program for patients with metabolic dysfunction. 

Josh Lehrer

Josh Lehrer, M.D.(LinkedIn)

Taking the charge is CEO Josh Lehrer, M.D., who has been in the top spot since October 2023. Before joining the newly emerged Marea, Lehrer led Graphite Bio (now merged with LENZ Therapeutics) and previously spent more than six years in various leadership roles at Global Blood Therapeutics.

Lehrer is joined by Ethan Weiss, M.D., Marea co-founder and chief scientific officer. The cardiologist is also…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks